A pragmatic and successful approach to treating nonsmall-cell lung carcinoma.
Lung cancer is the single leading cause of cancer deaths for men and women combined. Nonsmall-cell lung carcinoma (NSCLC), which results largely from smoking tobacco, accounts for 87% of all lung cancer cases. Methods of patient selection, preoperative and intraoperative care, and postoperative outcomes for patients with NSCLC who were treated from 1991 through 2003 at Inova Fairfax Hospital are discussed. All patients were treated with surgery, some selectively and progressively with a combination of preoperative neoadjuvant therapy, to try to downstage the disease to make complete resection feasible. Outcomes from this data collection period match or exceed the best results for treatment of late-stage (ie, III and IV) disease reported anywhere to date.
Kiernan
Paul D
PD
Cardiovascular and Thoracic Surgical Associates, Annandale, VA, USA.
Graling
Paula R
PR
Hetrick
Vivian L
VL
Vaughan
Betty E
BE
Sheridan
Michael J
MJ
Lee
Johnny K
JK
D000368:Aged; D002289:Carcinoma, Non-Small-Cell Lung / Q000401:mortality / Q000451:nursing* / Q000601:surgery*; D017052:Hospital Mortality; D006801:Humans; D008168:Lung / Q000473:pathology / Q000601:surgery; D008175:Lung Neoplasms / Q000401:mortality / Q000451:nursing* / Q000601:surgery*; D008875:Middle Aged; D009367:Neoplasm Staging; D013527:Perioperative Nursing; D011300:Preoperative Care; D015996:Survival Rate